therealreal Archives - SA国际传媒 News /tag/therealreal/ Data-driven reporting on private markets, startups, founders, and investors Fri, 28 Jun 2019 15:04:11 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.5 /wp-content/uploads/cb_news_favicon-150x150.png therealreal Archives - SA国际传媒 News /tag/therealreal/ 32 32 HealthTech Startup Livongo Files For IPO With Quick Revenue Growth, Growing Losses /venture/healthtech-startup-livongo-files-for-ipo-with-quick-revenue-growth-growing-losses/ Fri, 28 Jun 2019 15:04:11 +0000 http://news.crunchbase.com/?p=19225 As The RealReal begins to trade, another technology IPO is coming into focus. Today, healthtech startup to go public with quick revenue growth, expanding losses, and a story outlining how it intends to replicate early success across more clients, and more illnesses.

Subscribe to the SA国际传媒 Daily

Livongo, founded in 2014 and based in Mountain View, during its life as a private company. Most recently, the firm led by and . Notably, both General Catalyst and Kinnevik co-led the firm’s , and the former firm led its . General Catalyst owns around a quarter of the company according to its S-1 filing.

Livongo claims to want to “empower people with chronic conditions to live better and healthier lives.” As far as corporate goals go, that’s not a bad approach to making money. Its model works by providing data collection tools (blood sugar testing devices for people with diabetes, for example) to users, coupled to a platform that tracks their personal data (and its progress or regression) and provides support.

Bringing actionable data and support to chronic illness sufferers is a good idea. Livongo has expanded from the diabetes market to other chronic conditions including hypertension and “prediabetes.” The company is also bringing its tech to bear on weight control, among other health issues.

As you can imagine, Livongo sells to large companies who roll its service out to 679 “clients” and 164,000 “members,” according to the company. In the first quarter of 2019, the company claims it added 50,000 of its members. That’s a lot for a single, three-month period given its preceding customer base.

How did that accretion of new users translate to growth in dollar terms? Let’s explore.

The Numbers

As an initial point of reference, Livongo sells its services to customers on a recurring, often multi-year contract basis. As such, we’re dealing with a SaaS-styled company, even though it deals with health issues and not, say, enterprise software.

To understand the company’s growth, let’s compare two time periods: its most recent set of full-year results, and its most-recent quarterly performance.

In yearly terms, Livongo grew from $30.9 million in revenue in 2017 to $68.4 million in 2018. That pace of growth, clocking in at over 100 percent, is the sort of expansion that investors (private and public alike) love to see. Its losses tracked higher at roughly the same percentage growth rate, rising from $16.9 million on a net basis to $33.4 million in the next year.

The company’s more recent performance is similarly sharp. In the first three months of 2018, Livongo posted revenue of $12.5 million, leading to a $4.2 million net loss. In the first three months of 2019, in contrast, Livongo generated revenue of $32.1 million, prompting a $15.0 million net loss. Again, each figure rising quickly as the firm ramps its sales and marketing, and general and administrative spending as its top line explodes.

Inside the headline numbers, the cost of Livongo’s growth is clearer. Observe the following chart tracking its cash consumption:

Translating, the company burned nearly as much cash across its operating and investing activities in the first quarter of 2019 than it did in all of 2018. So, Livongo is growing quickly, but at high expense. Investors likely won’t care given that its losses are merely tracking its revenue north as a manageable percentage, but the company’s cash position of $55.0 million at the end of Q1 2019 implies that it is going public now to raise capital to pay its bills.

Raising money in an IPO needed for operations is no sin, even if it feels retro in the era of Slack’s direct listing. But, Livongo is a company with a working model and a growth that many companies would kill for. All that’s left here is to figure out what the firm is worth, and get it out the door.

Illustration: .

]]>
/wp-content/uploads/2018/01/unicorn_1.png
The RealReal Prices IPO Above Range, Raising $300M /venture/the-realreal-prices-ipo-above-range-raising-300m/ Fri, 28 Jun 2019 13:26:27 +0000 http://news.crunchbase.com/?p=19219 Morning Markets: Luxury goods seller TheRealReal priced its IPO above range yesterday, extending a strong IPO cycle.

Subscribe to the SA国际传媒 Daily

closed above its IPO price yesterday, marking a return to form for the former darling of the technology and startup communities. After an IPO that featured lower-than-expected pricing and immediate value deletion, Uber clawing its way into the black could indicate that even 2019’s more troubled IPOs are finding favor with yet growth-hungry investors.

IPO pricing echoes the point. The luxury goods player priced its IPO above-range yesterday, landing at $20 per share, ahead of a $17 to $19 per-share range. Putting a sticker price on your shares above their indicated range isn’t unheard of — indeed, in strong markets, it can be a regular part of the IPO game — but it does mark a hot company, a hungry market, or both.

For The RealReal, the $20 per-share price put $300 million into its coffers from its 15 million shares sold. The final amount raised is right on target. As SA国际传媒 News wrote concerning this IPO earlier in June:

The firm will likely raise in the hundreds of millions, but less than $500 million.

Precisely.

The firm, which raised a touch under $300 million during its life as a private company (as reported, this includes “a聽 raised in July 2018,” including money from “,听,听,听,听,听听补苍诲听.”) will begin trading this morning under the ticker symbol “REAL.”

Finally, at $20 per share, The RealReal is worth around $1.7 billion. We’ll have a smidge more when it opens, and begins to trade. For now, this is yet another IPO that is in the books for the 2019 class.

Illustration: .

]]>
/wp-content/uploads/2018/08/money_clothesline.png